BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28104716)

  • 21. Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial.
    Vahanian A; Urena M; Walther T; Treede H; Wendler O; Lefèvre T; Spence MS; Redwood S; Kahlert P; Rodes-Cabau J; Leipsic J; Webb J
    EuroIntervention; 2016 Jun; 12(2):e235-43. PubMed ID: 27290682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.
    Chang HH; Chen IM; Chen PL; Hsu TL; Lin SM; Chen YH
    J Chin Med Assoc; 2015 Jun; 78(6):331-8. PubMed ID: 25823678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).
    Giannini C; Petronio AS; Mehilli J; Sartori S; Chandrasekhar J; Faggioni M; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Ferrer MC; Naber C; Kievit P; Sorrentino S; Morice MC; Chieffo A; Mehran R;
    Am J Cardiol; 2020 Feb; 125(3):441-448. PubMed ID: 31813530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry.
    Saia F; Gandolfo C; Palmerini T; Berti S; Doshi SN; Laine M; Marcelli C; Piva T; Ribichini F; De Benedictis M; Cardaioli F; Cannata S; Tarantini G
    EuroIntervention; 2020 Feb; 15(14):1240-1247. PubMed ID: 31763985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.
    Barbanti M; Baan J; Spence MS; Iacovelli F; Martinelli GL; Saia F; Bortone AS; van der Kley F; Muir DF; Densem CG; Vis M; van Mourik MS; Seilerova L; Lüske CM; Bramlage P; Tamburino C
    BMC Cardiovasc Disord; 2017 Oct; 17(1):259. PubMed ID: 29017461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI.
    Auffret V; Lefevre T; Van Belle E; Eltchaninoff H; Iung B; Koning R; Motreff P; Leprince P; Verhoye JP; Manigold T; Souteyrand G; Boulmier D; Joly P; Pinaud F; Himbert D; Collet JP; Rioufol G; Ghostine S; Bar O; Dibie A; Champagnac D; Leroux L; Collet F; Teiger E; Darremont O; Folliguet T; Leclercq F; Lhermusier T; Olhmann P; Huret B; Lorgis L; Drogoul L; Bertrand B; Spaulding C; Quilliet L; Cuisset T; Delomez M; Beygui F; Claudel JP; Hepp A; Jegou A; Gommeaux A; Mirode A; Christiaens L; Christophe C; Cassat C; Metz D; Mangin L; Isaaz K; Jacquemin L; Guyon P; Pouillot C; Makowski S; Bataille V; Rodés-Cabau J; Gilard M; Le Breton H;
    J Am Coll Cardiol; 2017 Jul; 70(1):42-55. PubMed ID: 28662806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and outcomes of patients ≤ 75 years who underwent transcatheter aortic valve implantation: insights from the SOURCE 3 Registry.
    Frank D; Abdel-Wahab M; Gilard M; Digne F; Souteyrand G; Caussin C; Collart F; Letocart V; Wöhrle J; Kuhn C; Hovorka T; Baumgartner H
    Clin Res Cardiol; 2019 Jul; 108(7):763-771. PubMed ID: 30552511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive ability of the CHADS2 and CHA2DS2-VASc scores for stroke after transcatheter aortic balloon-expandable valve implantation: an Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) sub-analysis.
    Conrotto F; D'Ascenzo F; D'Onofrio A; Agrifoglio M; Chieffo A; Cioni M; Regesta T; Tarantini G; Gabbieri D; Saia F; Tamburino C; Ribichini F; Cugola D; Aiello M; Sanna F; Iadanza A; Pompei E; Stolcova M; Cappai A; Minati A; Cassese M; Martinelli GL; Agostinelli A; Gerosa G; Gaita F; Rinaldi M; Salizzoni S
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):867-873. PubMed ID: 27354254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Outcome of Transcatheter Aortic Valve Implantation With Versus Without Previous Coronary Artery Bypass Grafting (from the FRANCE 2 Registry).
    Castellant P; Didier R; Bezon E; Couturaud F; Eltchaninoff H; Iung B; Donzeau-Gouge P; Chevreul K; Fajadet J; Leprince P; Leguerrier A; Lievre M; Prat A; Teiger E; Laskar M; Boschat J; Gilard M;
    Am J Cardiol; 2015 Aug; 116(3):420-5. PubMed ID: 26071993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midterm clinical outcome following Edwards SAPIEN or Medtronic Corevalve transcatheter aortic valve implantation (TAVI): Results of the Belgian TAVI registry.
    Collas VM; Dubois C; Legrand V; Kefer J; De Bruyne B; Dens J; Rodrigus IE; Herijgers P; Bosmans JM;
    Catheter Cardiovasc Interv; 2015 Sep; 86(3):528-35. PubMed ID: 25963917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry.
    Guerrero M; Dvir D; Himbert D; Urena M; Eleid M; Wang DD; Greenbaum A; Mahadevan VS; Holzhey D; O'Hair D; Dumonteil N; Rodés-Cabau J; Piazza N; Palma JH; DeLago A; Ferrari E; Witkowski A; Wendler O; Kornowski R; Martinez-Clark P; Ciaburri D; Shemin R; Alnasser S; McAllister D; Bena M; Kerendi F; Pavlides G; Sobrinho JJ; Attizzani GF; George I; Nickenig G; Fassa AA; Cribier A; Bapat V; Feldman T; Rihal C; Vahanian A; Webb J; O'Neill W
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1361-71. PubMed ID: 27388824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
    Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
    Kalra SS; Firoozi S; Yeh J; Blackman DJ; Rashid S; Davies S; Moat N; Dalby M; Kabir T; Khogali SS; Anderson RA; Groves PH; Mylotte D; Hildick-Smith D; Rampat R; Kovac J; Gunarathne A; Laborde JC; Brecker SJ
    JACC Cardiovasc Interv; 2017 Feb; 10(3):276-282. PubMed ID: 28183467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suprasternal Transcatheter Aortic Valve Replacement in Patients With Marginal Femoral Access.
    Kiser AC; Caranasos TG; Peterson MD; Holzhey DM; Kiefer P; Nifong LW; Borger MA
    Innovations (Phila); 2018; 13(1):1-4. PubMed ID: 29462049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter Aortic Valve Replacement With the Latest-Iteration Self-Expanding or Balloon-Expandable Valves: The Multicenter OPERA-TAVI Registry.
    Costa G; Saia F; Pilgrim T; Abdel-Wahab M; Garot P; Valvo R; Gandolfo C; Branca L; Latib A; Santos IA; Mylotte D; De Marco F; De Backer O; Franco LN; Akodad M; Mazzapicchi A; Tomii D; Laforgia P; Cannata S; Fiorina C; Scotti A; Lunardi M; Poletti E; Mazzucca M; Quagliana A; Hennessey B; Meier D; Adamo M; Sgroi C; Reddavid CM; Strazzieri O; Motta SC; Frittitta V; Dipietro E; Comis A; Melfa C; Thiele H; Webb JG; Søndergaard L; Tamburino C; Barbanti M
    JACC Cardiovasc Interv; 2022 Dec; 15(23):2398-2407. PubMed ID: 36121242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.